University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) will work under a formal collaboration with the Frederick National Laboratory for Cancer Research (operated by Leidos Biomedical Research, Inc.) to explore new candidate vaccines against human papillomavirus (HPV), a common cause of cervical cancer.
{iframe}https://www.ibbr.umd.edu/news/ibbr-and-frederick-national-lab-establish-human-papillomavirus-hpv-vaccine-development{/iframe}